Abiopharma

Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting

Agenus Inc. - Update: Agenus Aug 27 StakeholderWebcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight

Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight

Water Tower Research Fireside Chat with Ainos: AI Nose Sets New Bar in AI Scent Digitization, Eyes 2026 Scale-Up

New Form 8-K - Lipocine Inc. Filed: 2025-08-26 AccNo: 0001493152-25-012325 Size: 240 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Tharimmune, Inc. Filed: 2025-08-26 AccNo: 0001641172-25-025476 Size: 202 KB Item 1.01: Entry into a Material Definitive Agreement

New Form 6-K - DR REDDYS LABORATORIES LTD Filed: 2025-08-26 AccNo: 0001575872-25-000551 Size: 113 KB

New Form 8-K - Lineage Cell Therapeutics, Inc. Filed: 2025-08-26 AccNo: 0000950170-25-111319 Size: 247 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Westlake kondigt de overname aan van de activiteiten voor compound-oplossingen van ACI

Westlake annonce l’acquisition de l’activité de solutions de compoundage d’ACI

Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman

New Form 8-K - PULSE BIOSCIENCES, INC. Filed: 2025-08-26 AccNo: 0001437749-25-027725 Size: 173 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences

Philips Future Health Index cardiology snapshot reveals trust gap in AI for care

New Form 8-K - BIO-RAD LABORATORIES, INC. Filed: 2025-08-26 AccNo: 0000012208-25-000054 Size: 2 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits